Considering the multiple functions of DDX3X in this type of cancer, it is also impossible to predict survival outcomes of patients only using the DDX3X protein as a biomarker, since it seems to associate with different molecules that alter the tumor development. This evidence concerns the gene DDX3X and neoplasm.